Resistance to second-generation androgen receptor antagonists in prostate cancer
Keith T. Schmidt, Alwin D. R. Huitema, Cindy H. Chau, William D. Figg
Topics & Concepts
EnzalutamideMedicineProstate cancerOlaparibAndrogen receptorPARP inhibitorOncologyAbiraterone acetateAbirateroneInternal medicineCancerAndrogen deprivation therapyCancer researchPoly ADP ribose polymeraseBiologyBiochemistryGenePolymeraseProstate Cancer Treatment and ResearchPARP inhibition in cancer therapyProtein Degradation and Inhibitors